Cargando…
Colorectal tumour BRAF V600E and MLH1 promoter methylation status in the assessment of mismatch repair gene sequence variants of unknown clinical significance
Autores principales: | Parsons, M, Thompson, B, Goldgar, D, Hopper, J, Jenkins, M, Buchanan, D, Young, J, Spurdle, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327040/ http://dx.doi.org/10.1186/1897-4287-10-S2-A75 |
Ejemplares similares
-
Estimation of probabilities in favour of pathogenicity for missense substitutions for use in clinical evaluation of mismatch repair gene variants
por: Thompson, B, et al.
Publicado: (2012) -
Mismatch repair gene mutations and cancer risks: an update
por: Win, AK, et al.
Publicado: (2012) -
Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers
por: Dowty, JG, et al.
Publicado: (2012) -
The relationship between the BRAF p.V600E mutation and a family history of CRC in the early-onset CRC cases from the Australasian Colon Cancer Family Study
por: Buchanan, DD, et al.
Publicado: (2012) -
Mlh2 Is an Accessory Factor for DNA Mismatch Repair in Saccharomyces cerevisiae
por: Campbell, Christopher S., et al.
Publicado: (2014)